Orthopedics · Arthritis (Rheumatoid, Osteoarthritis, Crystal Arthropathy)

A 52-year-old man with chronic gout is on azathioprine for autoimmune hepatitis. He is started on allopurinol for recurrent gouty attacks. What is the major risk of this combination?

  • A Bone marrow suppression due to azathioprine toxicity
  • B Acute gout flare
  • C Severe hepatotoxicity
  • D Renal failure
Correct answer: A. Bone marrow suppression due to azathioprine toxicity

Explanation

Allopurinol inhibits xanthine oxidase, the enzyme responsible for metabolising azathioprine to inactive metabolites. When allopurinol is co-administered, azathioprine levels rise markedly, leading to severe bone marrow suppression, including leukopenia and thrombocytopenia. The azathioprine dose should be reduced to 25-33% of the usual dose when combined with allopurinol, or an alternative urate-lowering agent should be chosen. Hepatotoxicity and renal failure are not the primary concern with this interaction.

Reference: Katzung's Basic and Clinical Pharmacology, 15th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Arthritis (Rheumatoid, Osteoarthritis, Crystal Arthropathy) MCQs

See all Arthritis (Rheumatoid, Osteoarthritis, Crystal Arthropathy) MCQs →